Texas 2023 - 88th Regular

Texas House Bill HB4801 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New	Differences
1	1	88R15237 JSC-D
2	2	By: Talarico H.B. No. 4801
3	3
4	4
5	5	A BILL TO BE ENTITLED
6	6	AN ACT
7	7	relating to the use of the money in the Opioid Abatement Account.
8	8	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
9	9	SECTION 1. Section 403.505(d), Government Code, is amended
10	10	to read as follows:
11	11	(d) A state agency may use money appropriated from the
12	12	account only to:
13	13	(1) prevent opioid use disorder through
14	14	evidence-based education and prevention, such as school-based
15	15	prevention, early intervention, or health care services or programs
16	16	intended to reduce the risk of opioid use by school-age children;
17	17	(2) support efforts to prevent or reduce deaths from
18	18	opioid overdoses or other opioid-related harms, including through
19	19	increasing the availability or distribution of naloxone or other
20	20	opioid antagonists for use by health care providers, first
21	21	responders, persons experiencing an opioid overdose, families,
22	22	schools, community-based service providers, social workers, or
23	23	other members of the public;
24	24	(3) create and provide training on the treatment of
25	25	opioid addiction, including the treatment of opioid dependence with
26	26	each medication approved for that purpose by the United States Food
27	27	and Drug Administration, medical detoxification, relapse
28	28	prevention, patient assessment, individual treatment planning,
29	29	counseling, recovery supports, diversion control, and other best
30	30	practices;
31	31	(4) provide opioid use disorder treatment for youths
32	32	and adults, with an emphasis on programs that provide a continuum of
33	33	care that includes screening and assessment for opioid use disorder
34	34	and co-occurring behavioral health disorders, early intervention,
35	35	contingency management, cognitive behavioral therapy, case
36	36	management, relapse management, counseling services, and
37	37	medication-assisted treatments;
38	38	(5) provide patients suffering from opioid dependence
39	39	with access to all medications approved by the United States Food
40	40	and Drug Administration for the treatment of opioid dependence and
41	41	relapse prevention following opioid detoxification, including
42	42	opioid agonists, partial agonists, and antagonists;
43	43	(6) support efforts to reduce the abuse or misuse of
44	44	addictive prescription medications, including tools used to give
45	45	health care providers information needed to protect the public from
46	46	the harm caused by improper use of those medications;
47	47	(7) support treatment alternatives that provide both
48	48	psychosocial support and medication-assisted treatments in areas
49	49	with geographical or transportation-related challenges, including
50	50	providing access to mobile health services and telemedicine,
51	51	particularly in rural areas;
52	52	(8) address:
53	53	(A) the needs of persons involved with criminal
54	54	justice; and
55	55	(B) rural county unattended deaths; [or]
56	56	(9) purchase opioid antagonists in bulk from
57	57	manufacturers to decrease the price burden on organizations
58	58	distributing opioid antagonists to respond to opioid overdoses; or
59	59	(10) further any other purpose related to opioid
60	60	abatement authorized by appropriation.
61	61	SECTION 2. This Act takes effect immediately if it receives
62	62	a vote of two-thirds of all the members elected to each house, as
63	63	provided by Section 39, Article III, Texas Constitution. If this
64	64	Act does not receive the vote necessary for immediate effect, this
65	65	Act takes effect September 1, 2023.